v3.21.1
BIOLOGICAL ASSETS (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Reconciliation of changes in biological assets [abstract]    
Balance, at beginning of the year $ 2,935,144  
Acquired through combinations and acquisitions [Notes 1 & 4]   $ 3,760,158
Changes in fair value less costs to sell due to biological transformation 48,690,657 10,108,105
Production costs capitalized 8,936,001 3,542,005
Transferred to inventory upon harvest (48,491,951) (14,475,124)
Balance, at end of the year $ 12,069,851 $ 2,935,144